GHO Capital buys ClearView Healthcare Partners in continued North America push

The global strategy consulting firm for the life sciences industry commands a more than $700m valuation, concluding a Houlihan Lokey-conducted sale process.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this